Edition:
United States

Health News

Photo

J&J ordered to pay $417 million in trial over talc cancer risks 6:09pm EDT

A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

More Headlines

U.S. study revives argument over mammogram screening

(Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening.

12:23am EDT
Photo

Britain's Creo receives speedy FDA approval for its endoscopic device

LONDON Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.

7:56am EDT
Photo

New Novartis drug takes aim at tough-to-treat malaria

LONDON Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.

3:29am EDT
Photo

Shire's CFO resigns to join plant technology start-up

LONDON Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.

10:14am EDT

Health Watch Graphics